Paper42201618
Ameliorative effects of bevacizumab against sepsis-induced acute kidney injury: investigation of inflammatory responses, pyroptosis-related signalling and angiogenesis in a murine model of polymicrobial sepsis.
Qassam H and 5 others. Mol Biol Rep, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Ameliorative effects of bevacizumab against sepsis-induced acute kidney injury: investigation of inflammatory responses, pyroptosis-related signalling and angiogenesis in a murine model of polymicrobial sepsis. Papers, record 42201618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42201618
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Ameliorative effects of bevacizumab against sepsis-induced acute kidney injury: investigation of inflammatory responses, pyroptosis-related signalling and angiogenesis in a murine model of polymicrobial sepsis.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bevacizumab | Major topic |
| Acute Kidney Injury | Major topic |
| Sepsis | Major topic |
| Animals | |
| Mice | |
| Pyroptosis | |
| Disease Models, Animal | |
| Male | |
| Signal Transduction | |
| Vascular Endothelial Growth Factor A | |
| Inflammation | |
| Kidney | |
| Mice, Inbred C57BL | |
| Angiogenesis |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38434585 | Maresin-1 Attenuates Sepsis-Associated Acute Kidney Injury via Suppressing Inflammation, Endoplasmic Reticulum Stress and Pyroptosis by Activating the AMPK/SIRT3 Pathway. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/38434585 | PubMed |
| 2 | 20482750 | Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. | Crit Care | 2010 | https://conductscience.org/library/papers/20482750 | PubMed |
| 3 | 35936894 | Prognostic role of elevated VEGF in sepsis: A systematic review and meta-analysis. | Front Physiol | 2022 | https://conductscience.org/library/papers/35936894 | PubMed |
| 4 | 37310569 | Knockout of Erbin promotes pyroptosis via regulating NLRP3/caspase-1/Gasdermin D pathway in sepsis-induced acute kidney injury. | Clin Exp Nephrol | 2023 | https://conductscience.org/library/papers/37310569 | PubMed |
| 5 | 38313162 | Targeting VEGF using Bevacizumab attenuates sepsis-induced liver injury in a mouse model of cecal ligation and puncture. | J Med Life | 2023 | https://conductscience.org/library/papers/38313162 | PubMed |
| 6 | 40441588 | JAK1/JAK2 inhibitor baricitinib ameliorates sepsis-induced acute kidney injury in rats. | Eur J Pharmacol | 2025 | https://conductscience.org/library/papers/40441588 | PubMed |
| 7 | 40270016 | Pyroptosis in sepsis-associated acute kidney injury: mechanisms and therapeutic perspectives. | Crit Care | 2025 | https://conductscience.org/library/papers/40270016 | PubMed |
| 8 | 40676712 | Dimethyl fumarate attenuates liver injury in a mouse model of cecal ligation and puncture by modulating inflammatory, angiogenic and pyroptotic pathways. | BMC Pharmacol Toxicol | 2025 | https://conductscience.org/library/papers/40676712 | PubMed |
| 9 | 39527461 | INHIBITING SIRT2 ATTENUATES SEPSIS-INDUCED ACUTE KIDNEY INJURY VIA FOXO1 ACETYLATION-MEDIATED AUTOPHAGY ACTIVATION. | Shock | 2025 | https://conductscience.org/library/papers/39527461 | PubMed |
| 10 | 37085944 | Serum vascular endothelial growth factor affects tissue fluid accumulation and is associated with deteriorating tissue perfusion and oxygenation in severe sepsis: a prospective observational study. | Eur J Med Res | 2023 | https://conductscience.org/library/papers/37085944 | PubMed |
| 11 | 23710641 | Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis. | Crit Care | 2013 | https://conductscience.org/library/papers/23710641 | PubMed |
| 12 | 31954465 | Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. | Lancet | 2020 | https://conductscience.org/library/papers/31954465 | PubMed |
| 13 | 41589213 | Nivolumab and bevacizumab attenuate cisplatin-induced hepatic inflammation and apoptosis in rats. | Hepatol Forum | 2026 | https://conductscience.org/library/papers/41589213 | PubMed |
| 14 | 34012408 | Long Non-coding RNA MEG3 Promotes Renal Tubular Epithelial Cell Pyroptosis by Regulating the miR-18a-3p/GSDMD Pathway in Lipopolysaccharide-Induced Acute Kidney Injury. | Front Physiol | 2021 | https://conductscience.org/library/papers/34012408 | PubMed |
| 15 | 35693810 | Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target. | Front Immunol | 2022 | https://conductscience.org/library/papers/35693810 | PubMed |
| 16 | 11108718 | Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11108718 | PubMed |
| 17 | 32182390 | ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. | J Leukoc Biol | 2020 | https://conductscience.org/library/papers/32182390 | PubMed |
| 18 | 17670897 | The role of ICAM-1 in endotoxin-induced acute renal failure. | Am J Physiol Renal Physiol | 2007 | https://conductscience.org/library/papers/17670897 | PubMed |
| 19 | 36737765 | Forsythiaside A ameliorates sepsis-induced acute kidney injury via anti-inflammation and antiapoptotic effects by regulating endoplasmic reticulum stress. | BMC Complement Med Ther | 2023 | https://conductscience.org/library/papers/36737765 | PubMed |
| 20 | 36012420 | Sepsis and Acute Kidney Injury: A Review Focusing on the Bidirectional Interplay. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36012420 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42201618
GET https://conductscience.org/api/papers/v1/42201618/references?page=2